Clinical Report: Stage-Gated bpMRI Reporting Enhances Prostate Cancer Screening Accuracy

Overview

A retrospective analysis of the IP1-PROSTAGRAM dataset evaluated a two-step 'stage-gated' reporting approach for biparametric MRI (bpMRI) in prostate cancer screening. This method, involving initial limited sequence review followed by full bpMRI assessment in selected cases, improved positive predictive value (PPV) compared to conventional Likert/PI-RADS scoring.

Background

Prostate cancer screening faces challenges balancing mortality reduction with harms from overdiagnosis and unnecessary biopsies. PSA testing, while reducing mortality, has limitations including low specificity. Incorporating MRI, particularly abbreviated biparametric protocols, may improve detection of clinically significant prostate cancer and reduce unnecessary biopsies. Conventional MRI scoring systems were designed for diagnostic rather than screening populations, resulting in lower PPV in low-prevalence settings. The ReIMAGINE study demonstrated high PPV using a two-stage MRI approach, prompting evaluation of a similar stage-gated reporting strategy on a single bpMRI exam.

Data Highlights

The retrospective study re-evaluated 405 bpMRI scans using a stage-gated approach: initial review of axial T2-weighted imaging and high b-value diffusion-weighted imaging by three expert radiologists, followed by full bpMRI review in screen-positive cases. Advancement criteria included consensus positivity or elevated PSA density (≥ 0.12 ng/mL2) in discordant cases. Biopsy recommendations were based on PI-RADS scores ≥ 4 or PI-RADS 3 with elevated PSA density. This approach aimed to improve specificity while maintaining sensitivity in a screening population.

Key Findings

• The stage-gated approach used limited sequences (axial T2WI and b1500 DWI) for initial screening, reducing unnecessary full bpMRI reviews.
• Screen-positive classification required concordant abnormalities on both sequences, enhancing specificity.
• In cases of reader discordance, elevated PSA density was used to advance scans to full bpMRI review, preserving sensitivity.
• Full bpMRI review applied adapted PI-RADS v2.1 scoring to refine biopsy recommendations.
• This method improved the positive predictive value of bpMRI in prostate cancer screening compared to conventional Likert/PI-RADS scoring systems designed for diagnostic settings.

Clinical Implications

The stage-gated reporting strategy offers a practical and efficient approach to prostate cancer screening MRI interpretation by focusing initial assessment on key sequences and selectively advancing cases for full review. This method may reduce unnecessary biopsies and overdiagnosis by improving specificity without compromising sensitivity. Incorporating PSA density thresholds in equivocal cases further refines decision-making, supporting more targeted biopsy recommendations.

Conclusion

A two-step stage-gated bpMRI reporting approach enhances the accuracy of prostate cancer screening by improving positive predictive value and balancing sensitivity and specificity. This strategy has potential to optimize MRI use in population-based screening programs.

References

1. European Commission 2020 -- Recommendations on Organised Prostate Cancer Screening
2. IP1-PROSTAGRAM Study 2021 -- Population-Based Prostate Cancer Screening with MRI
3. ReIMAGINE Screening Study 2023 -- Abbreviated Biparametric MRI for Prostate Cancer Screening
4. PI-RADS v2.1 2019 -- Prostate Imaging Reporting and Data System